Potential therapeutic effects of a traditional Chinese formulation, BJ-JN, on liver fibrosis induced by carbon tetrachloride in rats

Journal of Ethnopharmacology

Volumn 120, Issue 3, 2008, Pages 452-457

  Zou, Yu Hong ^a,b   Yang, Yan ^a   Li, Jun ^a   Wu, Qing ^a   Li, Wei Ping ^a   Lu, Jin Tao ^a   Roberts, Michael S ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

BJ JN; Hepatic stellate cell; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CHINESE DRUG; CURCUMA WENYUJIN EXTRACT; HYALURONIC ACID; MALONALDEHYDE; NITRIC OXIDE; PAEONIA LACTIFLORA EXTRACT; POLYPORUS UMBELLATUS EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; YUZHU XIAOGU;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AVIAN STOMACH; BETEL NUT; CELL PROLIFERATION; CHEMICAL COMPOSITION; CHICKEN; CHINESE MEDICINE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CURCUMA WENYUJIN; FIBROGENESIS; HISTOPATHOLOGY; LIVER FIBROSIS; LIVER PROTECTION; MALE; NONHUMAN; POLYPORUS UMBELLATUS; RAT; SPLEEN; STELLATE CELL; TRIONYX SINENSIS;

ANIMALS; CARBON TETRACHLORIDE; CARBON TETRACHLORIDE POISONING; DRUGS, CHINESE HERBAL; HEPATIC STELLATE CELLS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MEDICINE, CHINESE TRADITIONAL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN;

RATTUS;

EID: 56349136069     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.09.023     Document Type: Article

References (30)

1. Alpini G., Phillips J.O., Vroman B., and LaRusso N.F. Recent advances in the isolation of liver cells. Hepatology 20 (1994) 494-514
2. Bataller R., and Brenner D.A. Hepatic stellate cells as a target for the treatment of liver fibrosis. Seminars in Liver Disease 21 (2001) 437-451
3. Bataller R., and Brenner D.A. Liver fibrosis. Journal of Clinical Investigation 115 (2005) 209-218
4. Beljaars L., Meijer D.K., and Poelstra K. Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis. Frontiers in Bioscience 7 (2002) e214-222
5. Castilla-Cortazar I., Garcia M., Muguerza B., Quiroga J., Perez R., Santidrian S., and Prieto J. Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology 113 (1997) 1682-1691
6. Eng F.J., and Friedman S.L. Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. American Journal of Physiology. Gastrointestinal and Liver Physiology 279 (2000) G7-G11
7. Forbes S.J., Russo F.P., Rey V., Burra P., Rugge M., Wright N.A., and Alison M.R. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126 (2004) 955-963
8. Friedman S.L., and Roll F.J. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Analytical Biochemistry 161 (1987) 207-218
9. Gasso M., Rubio M., Varela G., Cabre M., Caballeria J., Alonso E., Deulofem R., Camps J., Gimenez A., Pajares M., Pares A., Mato J.M., and Rodes J. Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. Journal of Hepatology 25 (1996) 200-205
10. Gressner A.M. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney International. Supplement 54 (1996) S39-45
11. Gressner A.M., and Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. Journal of Cellular and Molecular Medicine 10 (2006) 76-99
12. 4-induced cirrhosis: protective role of adenosine administration. Hepatology 26 (1997) 1100-1110
13. Hu X.P., Wu Y.Y., Zhu H., Xu M., Zou Y.H., Kuang L.X., Yang Y., and Chen M.Z. The anti-hepatic fibrosis effects of BJ-JN and its mechanism of action. Acta Universitatis Medicinalis Anhui 40 (2005) 141-143
14. Kim Y.M., and Son K. A nitric oxide production bioassay for interferon-gamma. Journal of Immunological Methods 198 (1996) 203-209
15. Lamireau T., Desmouliere A., Bioulac-Sage P., and Rosenbaum J. Mechanisms of hepatic fibrogenesis. Archives de Pediatrie 9 (2002) 392-405
16. Lee K.S., Buck M., Houglum K., and Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. Journal of Clinical Investigation 96 (1995) 2461-2468
17. Liu J., McIntosh H., and Lin H. Chinese medicinal herbs for chronic hepatitis B: a systematic review. Liver 21 (2001) 280-286
18. Luckey S.W., and Petersen D.R. Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Experimental and Molecular Pathology 71 (2001) 226-240
19. Muriel P., and Escobar Y. Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride. Journal of Applied Toxicology 23 (2003) 103-108
20. Nie Q.H., Cheng Y.Q., Xie Y.M., Zhou Y.X., and Cao Y.Z. Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis. World Journal of Gastroenterology 7 (2001) 363-369
21. Okazaki I., Watanabe T., and Inagaki Y. Recent advance in understanding mechanisms of fibrogenesis and fibrolysis in hepatic fibrosis. Nippon Shokakibyo Gakkai Zasshi. The Japanese Journal of Gastroenterology 99 (2002) 353-364
22. Polavarapu R., Spitz D.R., Sim J.E., Follansbee M.H., Oberley L.W., Rahemtulla A., and Nanji A.A. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 27 (1998) 1317-1323
23. Poli G., and Parola M. Oxidative damage and fibrogenesis. Free Radical Biology and Medicine 22 (1997) 287-305
24. Saperstein L.A., Jirtle R.L., Farouk M., Thompson H.J., Chung K.S., and Meyers W.C. Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology 19 (1994) 412-417
25. Song S.G., Yang Y., and Cheng M.Z. Isolation and culture of Ito and Kupffer cell from rat liver. Chinese Journal of Clinical Pharmacology and Therapeutics 5 (2000) 351-353
26. Wu J., and Zern M.A. Hepatic stellate cells: a target for the treatment of liver fibrosis. Journal of Gastroenterology 35 (2000) 665-672
27. Wu Q., Yang Y., Xue S.L., Zhang X.X., Zou Y., and Chen M. Effect of astragalosides on proliferation and collagen production of hepatic stellate cells in vitro. Chinese Pharmacological Bulletin 19 (2003) 892-895
28. Yang H.Y., Li J., and Yi M. Study on chronical hepatitis B with treatment of integrative traditional Chinese and Western medicine. Zhongguo Zhong Yao Za Zhi 31 (2006) 1277-1280
29. Zhang J.T. Modern Experimental Methods in Pharmacology (Xian Dai Yao Li Shi Yan Fang Fa Xue) (1998), Beijing Medical University Press, Beijing p. 1398
30. Zou Y., Yang Y., Li J., Li W., and Wu Q. Prevention of hepatic injury by a traditional Chinese formulation, BJ-JN, in mice treated with Bacille-Calmette-Guerin and lipopolysaccharide. Journal of Ethnopharmacology 107 (2006) 442-448